Health

PrEP drug highly effective at reducing risk of HIV, study says



NHS England’s national director for specialised commissioning, John Stewart, added: “Not only did the trial directly prevent many cases of HIV, help normalise the use of PrEP, remove stigma and pave the way for a routinely commissioned clinically and cost effective PrEP service, but it also made a very real contribution towards our goal of ending new cases of HIV by 2030.”



READ SOURCE

Readers Also Like:  Bizarre dementia symptoms revealed after Bruce Willis' diagnosis

This website uses cookies. By continuing to use this site, you accept our use of cookies.